1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health - Common Fund. This program funds the development and validation of multimodal AI Clinical Decision Support (CDS) tools to improve patient care, requiring existing prototypes and access to comprehensive datasets.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Requires existing prototypes and access to comprehensive datasets. Confirm the full requirements in the official notice before applying.
Applications for Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional) are due October 19, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional) is funded by U.S. Department of Health and Human Services, National Institutes of Health - Common Fund. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health - Common Fund. The Validation Center will serve as a hub for validating AI-enabled, multimodal Clinical Decision Support (CDS) tools, supporting reproducibility, interoperability, and clinical translation.
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health - Common Fund. This opportunity funds the creation of a Logistics Center to coordinate PRIMED-AI activities, fostering collaboration and standardization in AI-based clinical data integration.
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health - Common Fund. Supports the development of innovative multimodal AI-based clinical decision support tools to improve patient care. This program is part of the broader Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Program.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article